ALCANZA INCLUSIVE CLINICAL RESEARCH Trademark

Trademark Overview


On Friday, April 8, 2022, a trademark application was filed for ALCANZA INCLUSIVE CLINICAL RESEARCH with the United States Patent and Trademark Office. The USPTO has given the ALCANZA INCLUSIVE CLINICAL RESEARCH trademark a serial number of 97353268. The federal status of this trademark filing is REGISTERED as of Tuesday, February 20, 2024. This trademark is owned by Alcanza Clinical Research, LLC. The ALCANZA INCLUSIVE CLINICAL RESEARCH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

scientific research in the field of health care; clinical medical research; medical and scientific research, namely, conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others; clinical medical and scientific research in the form of clinical trials of drugs for third party manufacturers; clinical scientific research in the form of clinical trials of drugs for third party manufacturers; laboratory research in the field of pharmaceuticals
alcanza inclusive clinical research

General Information


Serial Number97353268
Word MarkALCANZA INCLUSIVE CLINICAL RESEARCH
Filing DateFriday, April 8, 2022
Status700 - REGISTERED
Status DateTuesday, February 20, 2024
Registration Number7311297
Registration DateTuesday, February 20, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements


Translation of Words in MarkThe English translation of ALCANZA in the mark is REACH.
Disclaimer with Predetermined Text"INCLUSIVE CLINICAL RESEARCH"
Goods and Servicesscientific research in the field of health care; clinical medical research; medical and scientific research, namely, conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others; clinical medical and scientific research in the form of clinical trials of drugs for third party manufacturers; clinical scientific research in the form of clinical trials of drugs for third party manufacturers; laboratory research in the field of pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 12, 2022
Primary Code042
First Use Anywhere DateThursday, November 30, 2023
First Use In Commerce DateThursday, November 30, 2023

Trademark Owner History


Party NameAlcanza Clinical Research, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLake Mary, FL 32746

Party NameAlcanza Clinical Research, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLake Mary, FL 32746

Party NameAlcanza Clinical Research, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMethuen, MA 01844

Trademark Events


Event DateEvent Description
Tuesday, February 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 20, 2024REGISTERED-PRINCIPAL REGISTER
Monday, January 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 29, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 29, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 29, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 29, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 17, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 16, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 30, 2023USE AMENDMENT FILED
Tuesday, December 19, 2023SOU EXTENSION 1 GRANTED
Thursday, November 30, 2023SOU EXTENSION 1 FILED
Tuesday, December 19, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 30, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 30, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, June 6, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 26, 2023NON-FINAL ACTION E-MAILED
Thursday, January 26, 2023NON-FINAL ACTION WRITTEN
Thursday, January 26, 2023ASSIGNED TO EXAMINER
Tuesday, April 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 12, 2022NEW APPLICATION ENTERED